Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.93 USD | +2.51% | -4.84% | +76.25% |
Mar. 26 | Stifel Adjusts Spyre Therapeutics' Price Target to $54 From $36, Maintains Buy Rating | MT |
Mar. 18 | Spyre Therapeutics, Inc. announced that it expects to receive $180.005 million in funding | CI |
- Stock
- Equities
- Stock Spyre Therapeutics, Inc. - Nasdaq
- News Spyre Therapeutics, Inc.